A federal appeals court has issued a ruling that restricts abortion access across the United States. The decision specifically targets the availability of mifepristone, a commonly used abortion pill.
The court's action temporarily halts the ability to receive abortion medication through mail services. This ruling effectively blocks a previous Food and Drug Administration (FDA) regulation that permitted women to obtain these drugs via mail.
This move by the appeals court tightens nationwide access to abortion pills. This is a developing story and will be updated as details emerge.
